Michael E Pichichero MD
Medical Microbiology, Pediatric Vaccinology and Vaccine Preventable Diseases
Director and Vice President, Rochester General Hospital Research Institute
Join to View Full Profile
1425 Portland AvenueResearch InstituteRochester, NY 14621
Phone+1 585-922-5959
Dr. Pichichero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a physician scientist. My research is clinical and translational, involving vaccine development and pediatric respiratory disease diagnosis, epidemiology, pathogenesis and treatment.
Education & Training
University of Rochester Medical CenterResidency, Pediatrics, 1978 - 1981
University of ColoradoResidency, Pediatrics, 1976 - 1978
University of Rochester School of Medicine and DentistryClass of 1976- University of Rochester Medical CenterFellowship, Allergy and Immunology
- University of Rochester Medical CenterFellowship, Pediatric Infectious Diseases
Certifications & Licensure
NY State Medical License 1979 - 2026
American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- Correction: Respiratory infection‑ and asthma‑prone, low vaccine responder children demonstrate distinct mononuclear cell DNA methylation pathways.David Martino, Nikki Schultz, Ravinder Kaur, Simon D van Haren, Nina Kresoje
Clinical Epigenetics. 2025-03-28 - Eighteen Year Longitudinal Study of Uncomplicated and Complex Acute Otitis Media during the Pneumococcal Conjugate Vaccine Era, 2006-2023.Naoko Fuji, Frank N Salamone, Ravinder Kaur, Peter Bajorski, Eduardo Gonzalez
The Journal of Infectious Diseases. 2025-03-20 - Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, dur...Naoko Fuji, Eduardo Gonzalez, Frank N Salamone, Peter Bajorski, Ravinder Kaur
Vaccine. 2025-03-08
Press Mentions
- Immunity Debt and the TripledemicDecember 7th, 2022
- New Study: Can Antibiotics Lower Vaccine Response in Infants?April 30th, 2022
- Antibiotic Use in Young Children Tied to Reduced Vaccine ResponseApril 28th, 2022
- Join now to see all
Grant Support
- Haemophilus influenzae lipoprotein fusion vaccine and lipoprotein vaccine platform developmentROCHESTER GENERAL HOSPITAL (NY)2024–2029
- Haemophilus influenzae lipoprotein fusion vaccine and lipoprotein vaccine platform developmentROCHESTER GENERAL HOSPITAL (NY)2024–2029
- A Phase II Study Evaluating the Safety and Efficacy of Whole-Cell Pneumococcal Vaccine (wSp) in Reducing Nasopharyngeal Colonization by Streptococcus pneumoniae in Young ChildrenROCHESTER GENERAL HOSPITAL (NY)2024–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
